SalA attenuates ischemia/reperfusion-induced endothelial barrier dysfunction via down-regulation of VLDL receptor expression

Cellular Physiology and Biochemistry

Volumn 33, Issue 3, 2014, Pages 747-757

  Yang, Dan ^a   Zhang, Peng ^a   Wang, Tingfeng ^a   Gao, Lili ^a   Qiao, Zhengdong ^a   Liang, Yongjun ^a   Yu, Bo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Endothelial barrier dysfunction; Ischemia reperfusion; Salvianolic acid A; VLDL receptor

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; NOOTROPIC AGENT; PROTEIN ZO1; REACTIVE OXYGEN METABOLITE; SALVIANOLIC ACID A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PROTECTIVE AGENT; SALVIA MILTIORRHIZA EXTRACT; ALKENE; LOW DENSITY LIPOPROTEIN RECEPTOR; POLYPHENOL; SALVIANOLIC ACID;

ACTIN FILAMENT; ARTICLE; CELL MEMBRANE PERMEABILITY; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STRESS FIBER; UMBILICAL VEIN ENDOTHELIAL CELL; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME INACTIVATION; GENE OVEREXPRESSION; INTRACELLULAR SIGNALING; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; DRUG EFFECTS; METABOLISM; PATHOLOGY; VASCULAR ENDOTHELIUM;

ALKENES; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLYPHENOLS; RECEPTORS, LDL; REPERFUSION INJURY; RNA, MESSENGER;

EID: 84896432397     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358649     Document Type: Article

References (31)

1. Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D: Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory g proteins. J Exp Med 1989;169:1977-1991.
2. Wojciak-Stothard B, Entwistle A, Garg R, Ridley AJ: Regulation of tnf-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by rho, rac, and cdc42 in human endothelial cells. J Cell Physiol 1998;176:150-165.
3. Bogatcheva NV, Dudek SM, Garcia JG, Verin AD: Mitogen-activated protein kinases in endothelial pathophysiology. J Investig Med 2003;51:341-352.
4. Tacken PJ, Hofker MH, Havekes LM, van Dijk KW: Living up to a name: The role of the vldl receptor in lipid metabolism. Curr Opin Lipidol 2001;12:275-279.
5. Takahashi S, Sakai J, Fujino T, Miyamori I, Yamamoto TT: The very low density lipoprotein (vldl) receptor-a peripheral lipoprotein receptor for remnant lipoproteins into fatty acid active tissues. Mol Cell Biochem 2003;248:121-127.
6. Oganesian A, Armstrong LC, Migliorini MM, Strickland DK, Bornstein P: Thrombospondins use the vldl receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells. Mol Biol Cell 2008;19:563-571.
7. Jiang A, Hu W, Meng H, Gao H, Qiao X: Loss of vldl receptor activates retinal vascular endothelial cells and promotes angiogenesis. Invest Ophthalmol Vis Sci 2009;50:844-850.
8. Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, Chen SJ, Chen Z: Dissection of mechanisms of chinese medicinal formula realgar-indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A 2008;105:4826-4831.
9. Ho JH, Hong CY: Salvianolic acids: Small compounds with multiple mechanisms for cardiovascular protection. J Biomed Sci 2011;18:30.
10. Hempel SL, Haycraft DL, Hoak JC, Spector AA: Reduced prostacyclin formation after reoxygenation of anoxic endothelium. Am J Physiol 1990;259:C738-745.
11. Yang D, Guo S, Zhang T, Li H: Hypothermia attenuates ischemia/ reperfusion-induced endothelial cell apoptosis via alterations in apoptotic pathways and jnk signaling. FEBS Lett 2009;583:2500-2506.
12. Yang D, Xie P, Guo S, Li H: Induction of mapk phosphatase-1 by hypothermia inhibits tnf-alpha-induced endothelial barrier dysfunction and apoptosis. Cardiovasc Res 2010;85:520-529.
13. Yang D, Xie P, Liu Z: Ischemia/reperfusion-induced mkp-3 impairs endothelial no formation via inactivation of erk1/2 pathway. PLoS One 2012;7:e42076.
14. Gomez-Mendikute A, Cajaraville MP: Comparative effects of cadmium, copper, paraquat and benzo[a] pyrene on the actin cytoskeleton and production of reactive oxygen species (ros) in mussel haemocytes. Toxicol In Vitro 2003;17:539-546.
15. Breitenbach M, Laun P, Gimona M: The actin cytoskeleton, ras-camp signaling and mitochondrial ros in yeast apoptosis. Trends Cell Biol 2005;15:637-639.
16. Wallace BK, Jelks KA, O'Donnell ME: Ischemia-induced stimulation of cerebral microvascular endothelial cell na-k-cl cotransport involves p38 and jnk map kinases. Am J Physiol Cell Physiol 2012;302:C505-517.
17. Gao F, Yue TL, Shi DW, Christopher TA, Lopez BL, Ohlstein EH, Barone FC, Ma XL: P38 mapk inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of pmn accumulation. Cardiovasc Res 2002;53:414-422.
18. Lum H, Malik AB: Mechanisms of increased endothelial permeability. Can J Physiol Pharmacol 1996;74:787-800.
19. Raines EW, Ross R: Biology of atherosclerotic plaque formation: Possible role of growth factors in lesion development and the potential impact of soy. J Nutr 1995;125:624S-630S.
20. Baines CP, Molkentin JD: Stress signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 2005;38:47-62.
21. Choong G, Liu Y, Xiao W, Templeton DM: Cadmium-induced glutathionylation of actin occurs through a ros-independent mechanism: Implications for cytoskeletal integrity. Toxicol Appl Pharmacol 2013;272:423-430.
22. Lv P, Miao SB, Shu YN, Dong LH, Liu G, Xie XL, Gao M, Wang YC, Yin YJ, Wang XJ, Han M: Phosphorylation of smooth muscle 22alpha facilitates angiotensin ii-induced ros production via activation of the pkcdelta-p47phox axis through release of pkcdelta and actin dynamics and is associated with hypertrophy and hyperplasia of vascular smooth muscle cells in vitro and in vivo. Circ Res 2012;111:697-707.
23. Wyne KL, Pathak K, Seabra MC, Hobbs HH: Expression of the vldl receptor in endothelial cells. Arterioscler Thromb Vasc Biol 1996;16:407-415.
24. Loewen N, Chen J, Dudley VJ, Sarthy VP, Mathura JR Jr: Genomic response of hypoxic muller cells involves the very low density lipoprotein receptor as part of an angiogenic network. Exp Eye Res 2009;88:928-937.
25. Nakazato K, Ishibashi T, Nagata K, Seino Y, Wada Y, Sakamoto T, Matsuoka R, Teramoto T, Sekimata M, Homma Y, Maruyama Y: Expression of very low density lipoprotein receptor mrna in circulating human monocytes: Its up-regulation by hypoxia. Atherosclerosis 2001;155:439-444.
26. Yang XY, Qiang GF, Zhang L, Zhu XM, Wang SB, Sun L, Yang HG, Du GH: Salvianolic acid a protects against vascular endothelial dysfunction in high-fat diet fed and streptozotocin-induced diabetic rats. J Asian Nat Prod Res 2011;13:884-894.
27. Zhang YQ, Tang Y, Wu AL, Zhu HB: Salvianolic acid a displays cardioprotective effects in in vitro models of heart hypoxia/reoxygenation injury. J Asian Nat Prod Res 2010;12:899-915.
28. Oh KS, Oh BK, Mun J, Seo HW, Lee BH: Salvianolic acid a suppress lipopolysaccharide-induced nf-kappab signaling pathway by targeting ikkbeta. Int Immunopharmacol 2011;11:1901-1906.
29. Pan H, Li D, Fang F, Chen D, Qi L, Zhang R, Xu T, Sun H: Salvianolic acid a demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury. J Cardiovasc Pharmacol 2011;58:535-542.
30. Fan H, Yang L, Fu F, Xu H, Meng Q, Zhu H, Teng L, Yang M, Zhang L, Zhang Z, Liu K: Cardioprotective effects of salvianolic acid a on myocardial ischemia-reperfusion injury in vivo and in vitro. Evid Based Complement Alternat Med 2012;2012:508938.
31. Jiang M, Wang XY, Zhou WY, Li J, Wang J, Guo LP: Cerebral protection of salvianolic acid a by the inhibition of granulocyte adherence. Am J Chin Med 2011;39:111-120.